Developer of neuroimaging platform intended to create high-quality images from non-contrast CT and MRI scans.
Developer of neuroimaging platform intended to create high-quality images from non-contrast CT and MRI scans.
Decision/Risk Analysis📍 Golden, COFounded 2011
Current Valuation
$600M
as of 2023-Q3
PRIVATE
QL Price
$600M
0% vs last round
QuantLogix's current estimate for RapidAI, published 2026-09-27 — in line with the last disclosed round of $600M (2023-Q3).
Confidence
low
Basis
round anchored
What backs this price
Last disclosed round
$600M
2023-Q3
weight 0.13
How this price has held up
No round has priced for RapidAI since QuantLogix began publishing a price for it, so there is nothing to grade yet. The claim above is on the record from 2026-09-27 and will be graded against the next priced round. See the full accuracy record →
Which publicly-traded funds already hold it, what $10,000 buys, and whether any route is open to you.
Cite this price as QuantLogix QL Price, RapidAI, 2026-09-27 (22a8c57e7246236f).
The id pins this exact claim, so a citation stays checkable after the price moves.
Model estimate for research — not a quote, target price, or investment advice.
IPO Outlookprivate
Is RapidAI going public?
No. RapidAI is private and has not filed to go public. There is no S-1 on file.
What is RapidAI's valuation in 2026?
RapidAI is valued at $600M as of 2023-Q3, set by its Series C ($75M, Jul 2023). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has RapidAI filed an S-1?
No public S-1 is on file for RapidAI.
How much has RapidAI raised?
RapidAI has raised $103M in total, most recently a Series C of $75M in Jul 2023.
Is RapidAI publicly traded — can you buy RapidAI stock?
No. RapidAI is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for RapidAI on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
Founded
2011
HQ
Golden, CO
Employees
229
Total Raised
$103M
Last Round
Series C — $75M (Jul 2023)
IPO Status
private
Fundraising Status
Series C · $75M · 3y 2mo ago
privateTotal raised $103M
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$75M
Jul 2023
—
$600M
Talent Signal
Hiring trend
▲ Hiring uptrend
+50% vs 2026-08
Open roles
15
via lever
Product-build share
80%
engineering, research, product, design
Trajectory
expanding
heavy product build — 80% of open roles are product-building functions (engineering/research/product) — 9 of 15 open roles are engineering.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Clinical Data AnalsytClinical Success ConsultantLead Software EngineerLead Technical Support Engineer, DICOMPrincipal Software EngineerSenior Data Engineer
Counted from RapidAI's live job board as of 2026-09-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Health CareMedical DeviceHealth Diagnostics
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2023-Q3. Refreshed quarterly.